Intermediate process and cumulative effectiveness± of receiving two doses of SP and using an ITN with and without DOT in an eligible gestational age (4–8 months) among recently pregnant women not taking co-trimoxazole.

IPTp1: one dose of SP; IPTp2: two doses of SP; DOT: directly observed therapy; ITN: insecticide treated net; ANC: antenatal clinic; IPTp, intermittent preventive treatment; SP, sulfadoxine-pyrimethamine; N, denominator; n, numerator; CI confidence interval. †11 missing records. ±Intermediate process effectiveness represents coverage of women at each of the intermediate steps in the delivery of IPTp; ≠Cumulative systems effectiveness represents successful coverage of women for each of the intermediate steps up to that point in the delivery system.